Search

Author/Creator Montefiori, David C

1. Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection. Issue 5 (2nd May 2019)

Authors:
Pittala, Srivamshi; Bagley, Kenneth; Schwartz, Jennifer A; Brown, Eric P; Weiner, Joshua A; Prado, Ilia J; Zhang, Wenlei; Xu, Rong; Ota‐Setlik, Ayuko; Pal, Ranajit; Shen, Xiaoying; Beck, Charles; Ferrari, Guido; Lewis, George K; LaBranche, Celia C; Montefiori, David C; Tomaras, Georgia D; Alter, ...
Journal:
Molecular systems biology
Issue:
Volume 15:Issue 5(2019)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). Issue 10143 (21st July 2018)

Authors:
Barouch, Dan H; Tomaka, Frank L; Wegmann, Frank; Stieh, Daniel J; Alter, Galit; Robb, Merlin L; Michael, Nelson L; Peter, Lauren; Nkolola, Joseph P; Borducchi, Erica N; Chandrashekar, Abishek; Jetton, David; Stephenson, Kathryn E; Li, Wenjun; Korber, Bette; Tomaras, Georgia D; Montefiori, David C...
Journal:
Lancet
Issue:
Volume 392:Issue 10143(2018)
Page Start:
232
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals . (27th June 2022)

Authors:
Moy, James N; Anderson, Mark; Shen, Xiaoying; Fu, Jia; Stec, Michael; Gosha, Amy; Naquiallah, Dina; Kinslow, Jennifer; Montefiori, David C; Cloherty, Gavin; Landay, Alan
Journal:
Journal of infectious diseases
Issue:
Volume 226:Number 8(2022)
Page Start:
1407
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period. (4th January 2019)

Authors:
Spearman, Paul; Tomaras, Georgia D; Montefiori, David C; Huang, Ying; Elizaga, Marnie L; Ferrari, Guido; Alam, S Munir; Isaacs, Abby; Ahmed, Hasan; Hural, John; McElrath, M Juliana; Ouedraogo, Laissa; Pensiero, Michael; Butler, Chris; Kalams, Spyros A; Overton, Edgar Turner; Barnett, Susan W
Journal:
Journal of infectious diseases
Issue:
Volume 219:Number 11(2019)
Page Start:
1755
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial. Issue 11 (November 2019)

Authors:
Pantaleo, Giuseppe; Janes, Holly; Karuna, Shelly; Grant, Shannon; Ouedraogo, G Laissa; Allen, Mary; Tomaras, Georgia D; Frahm, Nicole; Montefiori, David C; Ferrari, Guido; Ding, Song; Lee, Carter; Robb, Merlin L; Esteban, Mariano; Wagner, Ralf; Bart, Pierre-Alexandre; Rettby, Nils; McElrath, M Ju...
Journal:
Lancet
Issue:
Volume 6:Issue 11(2019)
Page Start:
e737
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat. (25th September 2021)

Authors:
Gay, Cynthia L; James, Katherine S; Tuyishime, Marina; Falcinelli, Shane D; Joseph, Sarah B; Moeser, Matthew J; Allard, Brigitte; Kirchherr, Jennifer L; Clohosey, Matthew; Raines, Samuel L M; Montefiori, David C; Shen, Xiaoying; Gorelick, Robert J; Gama, Lucio; McDermott, Adrian B; Koup, Richard ...
Journal:
Journal of infectious diseases
Issue:
Volume 225:Number 5(2022)
Page Start:
856
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial. Issue 7 (July 2018)

Authors:
Bekker, Linda-Gail; Moodie, Zoe; Grunenberg, Nicole; Laher, Fatima; Tomaras, Georgia D; Cohen, Kristen W; Allen, Mary; Malahleha, Mookho; Mngadi, Kathryn; Daniels, Brodie; Innes, Craig; Bentley, Carter; Frahm, Nicole; Morris, Daryl E; Morris, Lynn; Mkhize, Nonhlanhla N; Montefiori, David C; Sarzo...
Journal:
Lancet
Issue:
Volume 5:Issue 7(2018)
Page Start:
e366
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗